- Case Report
- Open access
- Published:
Mesalazine-induced myopericarditis in a patient with ulcerative colitis
Echo Research & Practice volume 5, pages K1–K5 (2018)
Summary
A 25-year-old male with a background of ulcerative colitis presented with a two-week history of central chest pain. His ECG on presentation showed global T wave inversion with a peak troponin I of 165 ng/mL. Clinical diagnosis of myopericarditis/myocarditis was made. Echocardiography and cardiac magnetic resonance (MR) confirmed the diagnosis. On detailed assessment of his medication history, mesalazine was suspected as an etiological factor, with discontinuation resulting in an improvement in symptoms, inflammatory markers and cardiac enzymes. This is a unique case of mesalazine-induced myopericarditis on a background of inflammatory bowel disease.
References
Liu PP & Mason JW. Advances in the understanding of myocarditis. Circulation 2001104 1076–1082. https://doi.org/10.1161/hc3401.095198)
Freeman HJ & Salh B. Recurrent myopericarditis with extensive ulcerative colitis. Canadian Journal of Cardiology 201026 549–550. https://doi.org/10.1016/S0828-282X(10)70470-0)
Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R & Sechtem U. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004109 1250–1258. https://doi.org/10.1161/01.CIR.0000118493.13323.81)
Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. JACC 200953 1475–1487. https://doi.org/10.1016/j.jacc.2009.02.007)
Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG & Schulz-Menger J. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis. JACC 200545 1815–1822. https://doi.org/10.1016/j.jacc.2004.11.069)
Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal 201334 2636–2648. https://doi.org/10.1093/eurheartj/eht210)
Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, Klingel K, Kandolf R, Sechtem U, Cooper LT, et al. Update on myocarditis. JACC 201259 779–792. https://doi.org/10.1016/j.jacc.2011.09.074)
Katsanos KH & Tsianos EV. The heart in inflammatory bowel disease. Annals of Gastroenterology 200215 124–133.
Lacucci M, De Silva S & Ghosh S Mesalazine in inflammatory bowel disease: a trendy topic again? Canadian Journal of Gastroenterology 201024 127–133. https://doi.org/10.1155/2010/586092)
Funding
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.(http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
About this article
Cite this article
Asadi, J., Bhandari, S.S. & Ahmed, N. Mesalazine-induced myopericarditis in a patient with ulcerative colitis. Echo Res Pract 5, K1–K5 (2018). https://doi.org/10.1530/ERP-17-0044
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1530/ERP-17-0044